 "Mankind Pharma in fray to acquire Advent's stake in Bharat Serums: Report")
Don't want to miss the best from Business Standard?
New Delhi-based Mankind Pharma is planning to acquire Mumbai-based biopharma firm Bharat Serums and Vaccines (BSV) from private equity player Advent PE, according to media reports. Advent is seeking a $2 billion valuation for the 100 per cent stake it owns in BSV.
According to a report by CNBC-TV18, Advent is looking to exit BSV, which has been involved in women's health, critical care and emergency medicines, and assisted reproductive therapies for some time now. Business Standard was not able to verify the news till the time of going to press.
Mankind Pharma's stock surged 3.11 per cent on the Bombay Stock Exchange on Tuesday.
Emails sent to Mankind Pharma and BSV did not elicit any responses till the time of going to press. Advent PE refused to comment on the matter. BSV is projected to report earnings before interest, taxes, depreciation, and amortisation of Rs 500 crore by the end of FY24 and Rs 650 crore by the end of FY25.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%